Scholars Central

Conference abstractPublished 23 Oct 2019

InnovaƟ ve approach for uƟ lizaƟ on of high throughput sequencing in pharmacogenomics clinical pracƟ ce

Authors: Alireza Tafazoli

Medical University of Bialystok, Poland

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pharmacogenomics (PGx) mainly concerns the use of genomic data for drug administraƟ on in paƟ ents. 97-98% of all people have at least one high risk funcƟ onal genomic variaƟ on in their pharmacogenes and drug target genes, which could be idenƟfi ed through comprehensive genotyping methods like Next GeneraƟ on Sequencing (NGS) before prescripƟ on of medicines. Presymptomic profi ling of any genomic alteraƟ ons in all drug related genes through uƟ lizaƟ on of whole genome sequencing in individual works as a prognosƟ c screening approach for drug safety and efficacy and opens the true personalized drug therapy gates for future paƟ ents. Such pracƟ ces remove the Ɵ me for laboratories in preparing the results during the paƟ ents visit by clinicians and treatment procedures. The real Ɵ me personalized drug therapy will be implemented very fast in a close future via already prepared pharmacogenomics data in the local genomic databases, containing genomic variant informaƟ on for each separate paƟ ents in ethnic groups in a categorized and registered format.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Alireza Tafazoli”